Vista Oncology — Olympia, Washington

Vista Oncology is a clinical research site located in Olympia, Washington, United States 98506.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Vista Oncology has participated in 12 clinical trials with 10 currently active.

Therapeutic areas: Non Small Cell Lung Carcinoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma (FL).

Sponsors: AbbVie, Incyte Corporation, Genmab.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Olympia

Browse all research sites in Washington · View every site in Olympia

• Providence - Saint Peter Hospital
• St. Peters Hospital
• St. Peter Hospital
• Providence St Peter Hospital 413 Lilly RD NE
• Providence St. Peter Hospital
• Providence St. Peter Hospital Regional Cancer Center
• Capital Medical Center
• Research Site
• Novo Nordisk Investigational Site
• Capital Clin Res Ctr,LLC
• Local Institution

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vista Oncology?

Vista Oncology has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vista Oncology conducted?

Vista Oncology has 12 clinical trials on record, with 10 currently active. Their work covers Non Small Cell Lung Carcinoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma (FL).

Is Vista Oncology accredited by Crixeo Clinical Trials?

Vista Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vista Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.